QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
|
☒
|
Accelerated filer
|
☐
|
|||
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|||
Emerging growth company
|
|
Page No.
|
||||
3
|
||||
Item 1.
|
3
|
|||
3
|
||||
4
|
||||
5
|
||||
6
|
||||
7
|
||||
8
|
||||
Item 2.
|
25
|
|||
Item 3.
|
42
|
|||
Item 4.
|
43
|
|||
44
|
||||
Item 1.
|
44
|
|||
Item 1A.
|
44
|
|||
Item 2.
|
44
|
|||
Item 3.
|
44
|
|||
Item 4.
|
44
|
|||
Item 5.
|
44
|
|||
Item 6.
|
45
|
|||
46
|
Item 1. |
Interim Consolidated Financial Statements (Unaudited)
|
March 31,
2023
|
December 31,
2022
|
|||||||
(In thousands of U.S. dollars, except share data)
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Accounts receivable, net
|
|
|
||||||
Inventories, net
|
|
|
||||||
Other receivables
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Hedge collateral (Note 7)
|
|
|
||||||
Other current assets (Note 18)
|
|
|
||||||
Total current assets
|
|
|
||||||
Property, plant and equipment, net
|
|
|
||||||
Operating lease right-of-use assets
|
|
|
||||||
Intangible assets, net
|
|
|
||||||
Long-term prepaid expenses
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Other non-current assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
Liabilities and Stockholders’ Equity
|
||||||||
Current liabilities
|
||||||||
Accounts payable
|
$
|
|
$
|
|
||||
Other accounts payable
|
|
|
||||||
Accrued expenses (Note 6)
|
|
|
||||||
Accrued income taxes
|
|
|
||||||
Operating lease liabilities
|
|
|
||||||
Other current liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Accrued severance benefits, net
|
|
|
||||||
Non-current operating lease liabilities
|
|
|
||||||
Other non-current liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
Commitments and contingencies (Note 18)
|
||||||||
Stockholders’ equity
|
||||||||
Common stock, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Treasury stock,
|
(
|
)
|
(
|
)
|
||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Total stockholders’ equity
|
|
|
||||||
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
(In thousands of U.S. dollars, except share data)
|
||||||||
Revenues:
|
||||||||
Net sales – standard products business
|
$
|
|
$
|
|
||||
Net sales – transitional Fab 3 foundry services
|
|
|
||||||
Total revenues
|
|
|
||||||
Cost of sales:
|
||||||||
Cost of sales – standard products business
|
|
|
||||||
Cost of sales – transitional Fab 3 foundry services
|
|
|
||||||
Total cost of sales
|
|
|
||||||
Gross profit
|
|
|
||||||
Operating expenses:
|
||||||||
Selling, general and administrative expenses
|
|
|
||||||
Research and development expenses
|
|
|
||||||
Early termination charges
|
|
|
||||||
Total operating expenses
|
|
|
||||||
Operating income (loss)
|
(
|
)
|
|
|||||
Interest income
|
||||||||
Interest expense
|
(
|
)
|
(
|
)
|
||||
Foreign currency loss, net
|
(
|
)
|
(
|
)
|
||||
Other income (expense), net
|
(
|
)
|
|
|||||
Income (loss) before income tax expense
|
(
|
)
|
|
|||||
Income tax expense (benefit)
|
(
|
)
|
|
|||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
|||
Basic earnings (loss) per common share—
|
$
|
(
|
)
|
$
|
|
|||
Diluted earnings (loss) per common share—
|
$
|
(
|
)
|
$
|
|
|||
Weighted average number of shares—
|
||||||||
Basic
|
|
|
||||||
Diluted
|
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
(In thousands of U.S. dollars)
|
||||||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
|||
Other comprehensive loss
|
||||||||
Foreign currency translation adjustments
|
(
|
)
|
(
|
)
|
||||
Derivative adjustments
|
||||||||
Fair valuation of derivatives
|
(
|
)
|
(
|
)
|
||||
Reclassification adjustment for loss on derivatives included in net income (loss)
|
|
|
||||||
Total other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Total comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
Common Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Treasury Stock
|
Accumulated
Other
Comprehensive
Loss
|
Total
|
|||||||||||||||||||||||
(In thousands of U.S. dollars, except share data)
|
Shares
|
Amount
|
||||||||||||||||||||||||||
Three Months Ended March 31, 2023:
|
||||||||||||||||||||||||||||
Balance at December 31, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Stock-based compensation
|
—
|
|
|
|
|
|
|
|||||||||||||||||||||
Exercise of stock options
|
||||||||||||||||||||||||||||
Settlement of restricted stock units
|
|
|
(
|
) |
|
|
|
|
||||||||||||||||||||
Acquisition of treasury stock
|
(
|
)
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||
Other comprehensive loss, net
|
—
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Net loss
|
—
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
Balance at March 31, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Three Months Ended March 31, 2022:
|
||||||||||||||||||||||||||||
Balance at December 31, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Stock-based compensation
|
—
|
|
|
|
|
|
|
|||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Settlement of restricted stock units
|
|
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
Acquisition of treasury stock
|
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Accelerated stock repurchase
|
( |
) | ( |
) | ||||||||||||||||||||||||
Other comprehensive loss, net
|
—
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Net income
|
—
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance at March 31, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
(In thousands of U.S. dollars)
|
||||||||
Cash flows from operating activities
|
||||||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
|||
Adjustments to reconcile net income (loss) to net cash provided by operating activities
|
||||||||
Depreciation and amortization
|
|
|
||||||
Provision for severance benefits
|
|
|
||||||
Loss on foreign currency, net
|
|
|
||||||
Provision for inventory reserves
|
|
|
||||||
Stock-based compensation
|
|
|
||||||
Other, net
|
|
|
||||||
Changes in operating assets and liabilities
|
||||||||
Accounts receivable, net
|
|
(
|
)
|
|||||
Inventories
|
|
|
||||||
Other receivables
|
|
|
||||||
Other current assets
|
|
(
|
)
|
|||||
Accounts payable
|
|
|
||||||
Other accounts payable
|
(
|
)
|
(
|
)
|
||||
Accrued expenses
|
|
|
||||||
Accrued income taxes
|
(
|
)
|
(
|
)
|
||||
Other current liabilities
|
(
|
)
|
(
|
)
|
||||
Other non-current liabilities
|
(
|
)
|
(
|
)
|
||||
Payment of severance benefits
|
(
|
)
|
(
|
)
|
||||
Other, net
|
(
|
)
|
(
|
)
|
||||
Net cash provided by operating activities
|
|
|
||||||
Cash flows from investing activities
|
||||||||
Proceeds from settlement of hedge collateral
|
|
|
||||||
Payment of hedge collateral
|
(
|
)
|
(
|
)
|
||||
Purchase of property, plant and equipment
|
(
|
)
|
(
|
)
|
||||
Payment for intellectual property registration
|
(
|
)
|
(
|
)
|
||||
Payment of guarantee deposits
|
(
|
)
|
(
|
)
|
||||
Other, net
|
|
|
||||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
Cash flows from financing activities
|
||||||||
Proceeds from exercise of stock options
|
|
|
||||||
Acquisition of treasury stock
|
(
|
)
|
(
|
)
|
||||
Repayment of financing related to water treatment facility arrangement
|
(
|
)
|
(
|
)
|
||||
Repayment of principal portion of finance lease liabilities
|
(
|
)
|
(
|
)
|
||||
Net cash provided by (used in) financing activities
|
(
|
)
|
|
|||||
Effect of exchange rates on cash and cash equivalents
|
(
|
)
|
(
|
)
|
||||
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
|
|||||
Cash and cash equivalents at beginning of period
|
|
|
||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
Supplemental cash flow information
|
||||||||
Cash paid for income taxes
|
$
|
|
$
|
|
||||
Non-cash investing activities
|
||||||||
Property, plant and equipment additions in other accounts payable
|
$
|
|
$
|
|
||||
Non-cash financing activities
|
||||||||
Acquisition of treasury stock to satisfy the tax withholding obligations in connection with equity-based compensation
|
$
|
|
$
|
|
||||
Unsettled common stock repurchases
|
$
|
|
$
|
|
March 31,
2023
|
December 31,
2022
|
|||||||
Finished goods
|
$
|
|
$
|
|
||||
Semi-finished goods and work-in-process
|
|
|
||||||
Raw materials
|
|
|
||||||
Materials in-transit
|
|
|
||||||
Less: inventory reserve
|
(
|
)
|
(
|
)
|
||||
Inventories, net
|
$
|
|
$
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Change in reserve
|
||||||||
Inventory reserve charged to costs of sales
|
(
|
)
|
(
|
)
|
||||
Sale of previously reserved inventory
|
|
|
||||||
(
|
)
|
(
|
)
|
|||||
Write off
|
|
|
||||||
Translation adjustments
|
|
|
||||||
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
March 31,
2023
|
December 31,
2022
|
|||||||
Buildings and related structures
|
$
|
|
$
|
|
||||
Machinery and equipment
|
|
|
||||||
Finance lease right-of-use assets
|
|
|
||||||
Others
|
|
|
||||||
|
|
|||||||
Less: accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
Land
|
|
|
||||||
Construction in progress
|
|
|
||||||
Property, plant and equipment, net
|
$
|
|
$
|
|
March 31, 2023
|
||||||||||||
Gross
amount
|
Accumulated
amortization
|
Net
amount
|
||||||||||
Intellectual property assets
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
Intangible assets
|
$
|
|
$
|
(
|
)
|
$
|
|
December 31, 2022
|
||||||||||||
Gross
amount
|
Accumulated
amortization
|
Net
amount
|
||||||||||
Intellectual property assets
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
Intangible assets
|
$
|
|
$
|
(
|
)
|
$
|
|
Leases
|
Classification
|
March 31,
2023
|
December 31,
2022
|
||||||
Assets
|
|||||||||
Operating lease
|
Operating lease right-of-use assets
|
$
|
|
$
|
|
||||
Finance lease
|
Property, plant and equipment, net
|
|
|
||||||
Total lease assets
|
$
|
|
$
|
|
|||||
Liabilities
|
|||||||||
Current
|
|||||||||
Operating
|
Operating lease liabilities
|
$
|
|
$
|
|
||||
Finance
|
|
|
|
||||||
Non-current
|
|||||||||
Operating
|
Non-current operating lease liabilities
|
|
|
||||||
Finance
|
|
|
|
||||||
Total lease liabilities
|
$
|
|
$
|
|
March 31,
2023
|
December 31,
2022
|
|||||||
Weighted average remaining lease term
|
||||||||
Operating leases
|
|
|
||||||
Finance leases
|
|
|
||||||
Weighted average discount rate
|
||||||||
Operating leases
|
|
%
|
|
%
|
||||
Finance leases
|
|
%
|
|
%
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Operating lease cost
|
$
|
|
$
|
|
||||
Finance lease cost
|
||||||||
Amortization of right-of-use assets
|
|
|
||||||
Interest on lease liabilities
|
|
|
||||||
Total lease cost
|
$
|
|
$
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Cash paid for amounts included in the measurement of lease liabilities
|
||||||||
Operating cash flows from operating leases
|
$
|
|
$
|
|
||||
Operating cash flows from finance leases
|
|
|
||||||
Financing cash flows from finance leases
|
|
|
Operating
Leases
|
Finance
Leases
|
|||||||
Remainder of 2023
|
$
|
|
$
|
|
||||
2024
|
|
|
||||||
2025
|
|
|
||||||
2026
|
|
|
||||||
2027
|
|
|
||||||
Total future lease payments
|
|
|
||||||
Less: Imputed interest
|
(
|
)
|
(
|
)
|
||||
Present value of future payments
|
$
|
|
$
|
|
March 31,
2023
|
December 31,
2022
|
|||||||
Payroll, benefits and related taxes, excluding severance benefits
|
$
|
|
$
|
|
||||
Withholding tax attributable to intercompany interest income
|
|
|
||||||
Outside service fees
|
|
|
||||||
Others
|
|
|
||||||
Accrued expenses
|
$
|
|
$
|
|
Date of transaction
|
Total notional amount
|
Month of settlement
|
|||
|
$
|
|
to |
||
|
$
|
|
to |
||
|
$
|
|
to |
||
|
$
|
|
to |
Date of transaction
|
Total notional amount
|
Month of settlement
|
|||
|
$
|
|
to |
||
|
$
|
|
to |
||
$ |
to |
Derivatives designated as hedging instruments:
|
March 31,
2023
|
December 31,
2022
|
|||||||
Asset Derivatives: | |||||||||
Zero cost collars
|
$ |
$ |
|||||||
Liability Derivatives:
|
|||||||||
Zero cost collars
|
|
$
|
|
$
|
|
Gross amounts of
recognized
Assets/liabilities
|
Gross amounts
offset in the
balance sheets
|
Net amounts of
Assets/liabilities
presented in the
balance sheets
|
Gross amounts not offset
in the balance sheets
|
Net amount
|
||||||||||||||||||||
As of March 31, 2023
|
Financial
instruments
|
Cash collateral
pledged
|
||||||||||||||||||||||
Asset Derivatives:
|
||||||||||||||||||||||||
Zero cost collars
|
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Liability Derivatives:
|
||||||||||||||||||||||||
Zero cost collars
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Gross amounts of
recognized
liabilities
|
Gross amounts
offset in the
balance sheets
|
Net amounts of
liabilities
presented in the
balance sheets
|
Gross amounts not offset
in the balance sheets
|
Net amount
|
||||||||||||||||||||
As of December 31, 2022
|
Financial
instruments
|
Cash collateral
pledged
|
||||||||||||||||||||||
Liability Derivatives:
|
||||||||||||||||||||||||
Zero cost collars
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Derivatives in ASC
815 Cash Flow Hedging
Relationships
|
Amount of Loss
Recognized in
AOCI on
Derivatives
|
Location/Amount of
Loss
Reclassified from AOCI
Into Statement of Operations
|
Location/Amount of Loss
Recognized in
Statement of Operations on Derivatives
|
|||||||||||||||||||||||
Three Months Ended
March 31,
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
|
||||||||||||||||||||||||
2023
|
2022
|
2023
|
2022
|
2023
|
2022
|
|||||||||||||||||||||
Zero cost collars
|
$
|
(
|
)
|
$
|
(
|
)
|
|
$
|
(
|
)
|
$
|
(
|
)
|
Other income, net
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ |
( |
) |
Counterparty
|
March 31,
2023
|
December 31,
2022
|
||||||
SC
|
$
|
|
$
|
|
||||
Total
|
$ |
$ |
Carrying Value
March 31, 2023
|
Fair Value
Measurement
March 31, 2023
|
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||||||
Assets: |
||||||||||||||||||||
Derivative assets (other current assets)
|
$ |
$ |
|
$ |
||||||||||||||||
Liabilities:
|
||||||||||||||||||||
Derivative liabilities (other current liabilities)
|
$
|
|
$
|
|
|
$
|
|
|
|
Carrying Value
December 31, 2022
|
Fair Value
Measurement
December 31, 2022
|
Quoted Prices in
Active Markets
for Identical
Liability (Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||||||
Liabilities:
|
||||||||||||||||||||
Derivative liabilities (other current liabilities)
|
$
|
|
$
|
|
|
$
|
|
|
Three Months Ended |
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Beginning balance
|
$ | $ | ||||||
Provisions
|
||||||||
Severance payments
|
( |
) | ( |
) | ||||
Translation adjustments
|
( |
) | ( |
) | ||||
Less: Cumulative contributions to severance insurance deposit accounts
|
( |
) | ( |
) | ||||
The National Pension Fund
|
( |
) | ( |
) | ||||
Group severance insurance plan
|
( |
) | ( |
) | ||||
Accrued severance benefits, net
|
$ | $ |
Severance benefit
|
||||
Remainder of 2023
|
$
|
|
||
2024
|
|
|||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029 – 2033
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Revenues
|
||||||||
Standard products business
|
||||||||
Display Solutions
|
$
|
|
$
|
|
||||
Power Solutions
|
|
|
||||||
Total standard products business
|
$ |
|
$ |
|
||||
Transitional Fab 3 foundry services
|
|
|
||||||
Total revenues
|
$
|
|
$
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Gross Profit
|
||||||||
Standard products business
|
$
|
|
$
|
|
||||
Transitional Fab 3 foundry services
|
(
|
)
|
|
|||||
Total gross profit
|
$
|
|
$
|
|
Three Months Ended
|
||||||||
March 31,
2023
|
March 31,
2022
|
|||||||
Korea
|
$
|
|
$
|
|
||||
Asia Pacific (other than Korea)
|
|
|
||||||
United States
|
|
|
||||||
Europe
|
|
|
||||||
Total
|
$
|
|
$
|
|
March 31,
2023
|
December 31,
2022
|
|||||||
Foreign currency translation adjustments
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Derivative adjustments
|
(
|
)
|
(
|
)
|
||||
Total
|
$
|
(
|
)
|
$
|
(
|
)
|
Three Months Ended March 31, 2023
|
Foreign
currency
translation
adjustments
|
Derivative
adjustments
|
Total
|
|||||||||
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
Other comprehensive loss before reclassifications
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Amounts reclassified from accumulated other comprehensive loss
|
|
|
|
|||||||||
Net current-period other comprehensive loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Three Months Ended March 31, 2022
|
Foreign
currency
translation
adjustments
|
Derivative
adjustments
|
Total
|
|||||||||
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
Other comprehensive loss before reclassifications
|
(
|
)
|
(
|
)
|